Cargando…

Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention

Detalles Bibliográficos
Autores principales:	Chang, Haseong, Kim, Sung-Hea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588989/ https://www.ncbi.nlm.nih.gov/pubmed/34742175 http://dx.doi.org/10.3904/kjim.2021.466

Ejemplares similares

Triple troubles selecting optimal therapy for atrial fibrillation patients undergoing percutaneous coronary interventions
por: Parodi, Guido, et al.
Publicado: (2016)

Impact of Intensive Glucose Control in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: 3-Year Clinical Outcomes
por: Park, Jiesuck, et al.
Publicado: (2020)

Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
por: Kim, Sung Soo, et al.
Publicado: (2021)

Impact of Chronic Kidney Disease in Patients Undergoing Percutaneous Coronary Intervention: Improved but Not Solved
por: Ryu, Jae Kean, et al.
Publicado: (2017)

The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention
por: Yang, Jie, et al.
Publicado: (2021)

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Tao, Shiyi, et al.
Publicado: (2023)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

How Many Operators Are Optimal for Higher‐Risk Percutaneous Coronary Intervention Procedures?
por: Lee, Jinhyun, et al.
Publicado: (2021)

Mechanical circulatory support for percutaneous coronary intervention in high-risk patients undergoing transcatheter aortic valve replacement
por: Farag, Mohamed, et al.
Publicado: (2022)

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
por: Wang, Jing, et al.
Publicado: (2021)

Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention
por: Yong, Andy S. C., et al.
Publicado: (2018)

Left Main Coronary Artery Percutaneous Coronary Intervention
por: Ferrante, Arnaud, et al.
Publicado: (2022)

The effects of insulin therapy on mortality in diabetic patients undergoing percutaneous coronary intervention
por: Xu, Shaopeng, et al.
Publicado: (2021)

Quality of Life in Patients Undergoing Percutaneous Coronary Intervention
por: Tsoulou, Vasiliki, et al.
Publicado: (2023)

Coronary Artery Bypass Grafting Among Patients With Prior Percutaneous Coronary Interventions
por: Kahlon, Ravi S., et al.
Publicado: (2018)

Young coronary artery disease in patients undergoing percutaneous coronary intervention
por: Zuhdi, AS, et al.
Publicado: (2013)

Coronary Circulatory Indexes Before and After Percutaneous Coronary Intervention in a Porcine Tandem Stenoses Model
por: Chang, Haseong, et al.
Publicado: (2021)

Tailoring P2Y(12) Inhibiting Therapy in Elderly Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Capranzano, Piera, et al.
Publicado: (2019)

Diabetes Mellitus and Glucose as Predictors of Mortality in Primary Coronary Percutaneous Intervention
por: David, Renato Budzyn, et al.
Publicado: (2014)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
por: Guo, Xuantong, et al.
Publicado: (2023)

Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
por: Shoukat, Sana, et al.
Publicado: (2010)

Management of Atrial Fibrillation in Patients Undergoing Percutaneous Coronary Intervention
por: Mirra, M, et al.
Publicado: (2014)

Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions
por: Summaria, Francesco, et al.
Publicado: (2015)

Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
por: Ueki, Yasushi, et al.
Publicado: (2019)

J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Choi, Ik Jun, et al.
Publicado: (2021)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Park, Jangho, et al.
Publicado: (2021)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

The Importance of the First Jordanian Percutaneous Coronary Intervention Registry
por: Al-Suwaidi, Jassim
Publicado: (2017)

Special Issue “Clinical Frontiers in Percutaneous Coronary Intervention”
por: Beijk, Marcel A. M.
Publicado: (2023)

Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study
por: Yang, Yujin, et al.
Publicado: (2018)

Role of β-Blockers in Chronic Coronary Artery Disease Management in the Percutaneous Coronary Intervention Era: Good Symptom Control or Something More?
por: Roh, Ji Woong, et al.
Publicado: (2022)

Acute esophageal necrosis occurring in a patient undergoing percutaneous coronary intervention
por: Kwon, Hyung-Jin, et al.
Publicado: (2014)

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
por: Nusca, Annunziata, et al.
Publicado: (2015)

Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study
por: Wang, Yue, et al.
Publicado: (2022)

Treat or Not to Treat Non-culprit Coronary Artery with Significant Stenosis during Primary Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2018)

The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus
por: Lexis, Chris PH, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_47o16snbtdue55oi5rhq5aqfo7